tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Benjamin Burnett, 119 are a BUY (65.38%), 62 are a HOLD (34.07%), 1 are a SELL (0.55%).
Analyst Benjamin Burnett, currently employed at WELLS FARGO, carries an average stock price target met ratio of 46.93% that have a potential upside of 29.19% achieved within 111 days. Previously, Benjamin Burnett worked at STIFEL.
Benjamin Burnett’s has documented 355 price targets and ratings displayed on 28 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AXSM, Axsome Therapeutics at 13-Jan-2026.
Analyst best performing recommendations are on EFTR (EFFECTOR THERAPEUTICS).
The best stock recommendation documented was for CRSP (CRISPR THERAPEUTICS AG) at 2/13/2025. The price target of $49 was fulfilled within 1 day with a profit of $5.51 (12.67%) receiving and performance score of 126.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 09-Jan-2026
$5
$2.95 (143.90%)
1 months 15 days ago
(09-Jan-2026)
1/10 (10%)
$3.29 (192.40%)
148
Sell Since 10-Oct-2025
4 months 14 days ago
(10-Oct-2025)
0/3 (0%)
$2.86 (55.64%)
Buy Since 08-Oct-2021
7 months 17 days ago
(07-Jul-2025)
0/4 (0%)
$15.8 (97.53%)
Buy Since 08-Aug-2024
$10
9 months 9 days ago
(14-May-2025)
0/2 (0%)
$6.92 (224.68%)
Buy Since 05-Aug-2021
9 months 10 days ago
(14-May-2025)
2/9 (22.22%)
$12.2 (210.34%)
94
Which stock is Benjamin Burnett is most bullish on?
Which stock is Benjamin Burnett is most reserved on?
What Year was the first public recommendation made by Benjamin Burnett?
